|
|
| MRD / Regn No. |
: THBC\23-24\07137 |
Date |
: 23/06/2026 |
| Patient Name |
: Bharat Shah |
Age & Gender |
: 67 Yrs. / Male |
| Contact No. |
: 9322220345 |
UHID |
: |
| Ht / Wt / BMI |
: 165 / 75.95 / 27.90 |
BP S / BP D |
: 152 / 81 |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (15/Jul/2025) | DYSLIPIDEMIA (15/Jul/2015) | |
|
Subjective |
: |
T2DM X 20-25 YRS,HTN X 4-5 YRS,CALF PAIN BETTER,BPH - REDUCED FROM 75 GMS TO 39 GMS,METROPOLIS - 7.3%,GLAUCOMA CHANGES NOTED- VISION NORMAL,SMBG- IN NORMAL RANGE |
|
Objective |
: |
20-JUN-2026 REPORTS,FBS-98.75,HB-14.4/ HBA1C-6.7%,TC-114/ TG-87/ LDL-69/ HDL-35,VITD-52.5,VITB12-993,T3-106/ T4-9.8/ TSH-2.125,CR-1.1,TESTOSTERONE-463,ALT-19.9/ AST-17.9,MAGNESIUM-1.81,LIPASE-39.6,HSCRP-2.4,EGFR-73,AMYLASE-52.3,U ACR-16.6,22-JUN-2026 REPORTS,FBS-103/ PPBS-174 |
|
Analysis |
: |
OPTIDOZ - TELMISARTAN / HCTZ / AMLODIPINE,VIT D ONCE IN 15 DAYS,NUROKIND LC 2-3 TIMES A WEEK |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ZOMELIS SR 100 |
ORAL |
1-0-0 |
ABF
|
4 MTHS |
|
|
2 |
ROZAT F 10 MG |
ORAL |
0-0-1 |
AD
|
4 MTHS |
|
|
3 |
OPTIDOZ |
ORAL |
1-0-0 |
BBF
|
4 MTHS |
|
|
4 |
GEMER 0.5 / GLYCOMET GP 0.5 / GLIMISAVE M 0.5 / ZORYL M 0.5 MG |
ORAL |
1-0-1 |
BBF / BD
|
4 MTHS |
|
|
5 |
SILODOL D 8 MG |
ORAL |
0-0-1 |
AD
|
4 MTHS |
|
|
6 |
REFRESH TEARS |
ORAL |
1 DROP BOTH EYES |
2-3 TIMES A DAY
|
12 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 23/Oct/2026 |
| Tests Suggested For Next Visit |
: HBA1C REPEAT FROM METROPOLIS AS DISCREPANCY BETWEEN THYROCARE AND METROPOLIS (6.7% VS 7.3%),IF NXT HBA1C ALSO > 7% - CAN CONSIDER OPTIMISING MEDS |
| |
|
| |
|
|
